Candriam S.C.A. SPYRE THERAPEUTICS INC Transaction History
Candriam S.C.A.
- $16.9 Billion
- Q4 2024
Number of Shares
247,591
Previous 105,000
135.8%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%